血清脂蛋白(a)、胆红素水平与冠状动脉病变程度关系研究

目的 检测冠心病(CHD)患者的血清脂蛋白(a)和胆红素水平,并探讨其与CHD的关系.方法 对196例疑诊冠心病而接受冠状动脉造影的患者检测血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、脂蛋白(a)[Lp(a)]、总胆红素(TBIL)、直接胆红素(DBIL)、间接胆红素(IBIL).根据冠状动脉狭窄情况分为非冠心病组(冠状动脉狭窄小于50%,52例)、单支病变组(仅有一支冠状动脉分支狭窄大于或等于50%,53例)和多支病变组(有一支以上冠状动脉分支狭窄大于或等于50%,91例).分析影响冠状动脉病变的相关因素及冠状动脉病变程度与血脂、胆红素的关系.结果 各组间LDL-C、Lp(a)水平依次呈递增趋势,差异有统计学意义(P＜0.05)各组间间接胆红素水平呈依次递减趋势,多支病变组与非冠心病组、单支病变组差异有统计学意义(P＜0.05).单因素logistic回归结果表明血清脂蛋白(a)、间接胆红素均为影响冠状动脉病变的因素(回归系数分别2.125、-1.557,P＜0.01).进一步多因素logistic回归分析表明脂蛋白(a)对冠状动脉病变的影响要弱于低密度脂蛋白胆固醇、甘油三酯(0R值分别为1.238、5.031、3.996,95%CI分别为1.069-6.322、2.457-12.356、2.785-14.764).结论 血清Lp(a)水平升高、IBIL水平降低是CHD发病及病变程度的危险因素. Abstract： Objective To investigate the association of Lipoprotein (a) and bilirubin with coronary heart disease(CHD). Methods One hundred and ninty -six patients undergone coronary angiography and completed clinical examination of TC, TG, HDL - C, LDL - C, Lp ( a), TBIL, DBIL, IBIL were divided into the without coronary diseases group ( coronary artery stenosis ＜50% ,52 cases) ,the single vessel disease group(with only one vessel stenosis ≥50% ,53 cases) and the multi -vessel disease group (with more than one vessel stenosis ≥50% ,91 cases)according to the coronary angiographic results. The correlative factors of coronary lesion and the relationship between Lipid,bilirubin and the severity of coronary lesion were analyzed. Results Higher levels of LDL - C and Lp(a) were found in the single vessel disease group and in the multi -vessel disease group compared with the without coronary disease group, significant difference was found in the LDL- C and Lp(a) level among the 3 groups(P＜0.05). The levels of IBIL were lower in the single vessel disease group and in the multi -vessel disease group compared with the without coronary disease group,significant difference was found in indirect bilirubin level in the multi -vessel disease group compared with in the without coronary disease group and in the single vessel disease group(P＜0.05). Single factor logistic regression showed that Lp (a) and indirect bilirubin are both correlation factors with coronary lession (r =2. 125 and - 1. 557, P ＜0.01 respectively). Advanced multi - factor logistic regression showed weaker correlation of Lp (a) with coronary lesion compared with LDL - C and TG (OR = 1. 238,5.031 and 3.996,95% CI1.069 - 6.322,2.457 - 12.356,2.785 - 14.764 respectively). Conclusions High level of Lp(a) and Low level of IBIL in human significantly influence the severity of coronary heart disease(CHD).     

The relationship between plasma apolipoprotein A-Ⅳ levels and coronary heart disease

Objective To evaluate the relationship between plasma apoA-Ⅳ levels and coronary atheros clerosis and to explore its relation to other risk factors.Methods Using ELISA techniques, plasma apoA-Ⅳ levels were quantified in 181 patients w ho underwent coronary angiography (CAG).Patients were divided according to the ir coronary status into a coronary heart disease (CHD) group (stenotic lesion on CAG, n=118) and a control group (normal CAG, n=63).The severity of athero sclerosis was assessed by stenosis scoring of the different lesions.Other para meters, including apoA-Ⅰ,apoB, Lp(a), HDL-C, LDL-C, TG, and T C, were measured as well.Univariate, logistic regression analyses were used to define the relationship between coronary atherosclerosis and plasma apoA-Ⅳ levels.Results When compared with the control group, plasma apoA-Ⅳ levels were found to be lo wer in the CHD group.There was a weak negative correlation between plasma apoA -Ⅳ levels and the severity of coronary atherosclerosis.ApoA-Ⅳ was found to be a relatively independent risk factor for CHD.We also found a positive corr elation between apoA-Ⅳ and triglyceride levels.Conclusions ApoA-Ⅳ may be important in the prediction of CHD and coronary atherosclerosis severity.It may also play an important role in the metabolism of triglycerides .     

Combined effect of atorvastatin and probucol on plasma cystatin C levels and severity of coronary lesion in patients with borderline coronary lesion

Background  The plasma cystatin C concentration (PcyC) has been demonstrated to have prognostic value in acute coronary syndrome, but the study of PcyC in patients with borderline coronary lesions is limited. Moreover, the effects of atorvastatin and probucol on PcyC and the severity of coronary lesions are unknown. This study was to evaluate the effects of the combination of atorvastatin and probucol on PcyC and severity of coronary lesion in patients with borderline coronary lesions.

Methods  One hundred and thirty consecutive patients with borderline coronary lesions (40% to 60% isolated single stenosis assessed by quantitative coronary angiography) were enrolled into the borderline coronary lesion (BCL) group, and one hundred and thirty-six subjects without coronary lesions comprised the controls (CTR). The subjects in the BCL group were randomized into routine treatment (RTT, n=60), and combined treatment with atorvastatin 20 mg plus probucol 1.0 g daily added to routine medication (CBT, n=70), both groups were treated for 6 months continuously. The levels of PcyC, high-sensitive C-reactive protein (hs-CRP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) were determined. One hundred and four subjects in the BCL group were rechecked by coronary angiography.

Results  PcyC levels were significantly higher in the BCL group than in the CTR group; (2003.26±825.73) ng/ml vs. (1897.83±664.46) ng/ml (P <0.01). Compared with patients in the RTT group, the levels of PcyC, TC, LDL-C, TG and hs-CRP were significantly lower in the CBT group (P <0.05). Moreover, there was a trend towards a slight decrease in the RTT patients, (54.38±10.67)% vs. (50.29±9.89)% (P >0.05), and a significant decrease in the CBT patients, (53.65±9.48%) vs. (40.38±12.93)% (P <0.05), in the mean percent stenosis of borderline coronary lesions before and after six months of treatment.

Conclusions  Cystatin C played an important role in the development of coronary artery disease, and was associated with the severity of coronary lesions. The combination of atorvastatin and probucol decreased PcyC levels, and could be the treatment of choice.

     

脂蛋白相关磷脂酶A2与冠状动脉粥样硬化病变程度及斑块稳定性的关系

目的 探讨脂蛋白相关磷脂酶A2(Lp-PLA2)与冠状动脉粥样硬化病变程度及斑块稳定性的关系.方法 对160例可疑冠心病患者行冠状动脉造影,根据冠状动脉造影结果分为冠状动脉造影正常的对照组(34例)和冠心病组(126例),冠心病组根据临床类型分为急性冠状动脉综合征组(86例)和稳定型心绞痛组(40例).以病变支数和Gensini积分评价动脉粥样硬化病变程度,以临床类型评价斑块稳定性.检查所有患者血清Lp-PLA2水平、高敏C-反应蛋白(hs-CRP)等指标,分析Lp-PLA2、hs-CRP等与病变支数、Gensini积分、斑块稳定性的关系.结果 冠心病组Lp-PLA2水平显著高于对照组(P＜0.05),而且随着冠状动脉病变支数的增加和Gensini积分的增加而逐渐升高,在急性冠状动脉综合征组较稳定型心绞痛组升高.Lp-PLA2水平与hs-CRP无明显相关性.结论 冠心病患者血清Lp-PLA2水平与冠状动脉粥样硬化病变程度及斑块稳定性有关. Abstract： Objective To investigate the correlations between serum levels of lipoprotein -associated pospholipase A2 ( Lp - PLA2 ) and the severity and stability of coronary atherosclerosis. Methods Coronary angiography (CAG) was performed in 160 patients who were suspected as having coronary artery disease(CAD). According to the coronary artery chanrges and plaque characters in CAG, all patients were divided into control group( n =34) and CAD group( n = 126). According to the clinical types,the CAD patients were divided into acute coronary syndrome (ACS) group ( n = 86) and stable angina pectoris (SAP) group ( n = 40). The number of diseased coronary branches and Gensini' s score was used for evaluate the severity of atherosclerosis. The clinical types was used for evaluate the stability of plaque. Lp - PLA2 and hs - CRP were measured in all the patients. The correlation between serum LpPLA2 with hs - CRP and the number of diseased coronary branches, Gensini's score, clinical types were analyzed. Results Lp - PLA2 in CAD patients was significantly higher than that in control group ( P＜0.05) and increased with the increasing number of diseased coronary branches and Gensini's score.Lp -PLA2 in ACS group was higher than SAP group. Lp -PLA2 level had no correlated with hs -CRP.Conclusions CAD patients serum Lp - PLA2 level is correlated with the severity of atherosclerosis and the stability of plaque.     

Correlation of serum lipids, lipoproteins, lipid peroxide products and metals with coronary heart disease.

Serum lipids, lipoproteins, malondialdelyde (MDA) and metal levels were determined in 86 patients with coronary heart disease (CHD) proved angiographically and 33 controls subjects. Serum concentrations of TC, LDL-C, AI, MDA and Cu were significantly elevated and serum HDL-C, Zn and Mg contents were decreased markedly in patients. Correlation analyses indicated that the severity of coronary arterial lesions was related positively to serum TC, LDL-C, AI, MDA and Cu levels, and inversely to HDL-C levels; both the serum Cu and MDA contents were related positively to TC and LDL-C levels. These data suggest that serum Cu and MDA might have effects on the extent of CA lesions during the progress of atherosclerosis in patients with CHD.

     

D-二聚体与纤维蛋白原在冠心病中的临床意义

目的 研究D-二聚体(D-Dimer,DD)与纤维蛋白原(Fg)的含量在冠心病患者中的差异.方法 将入选的130例经冠状动脉造影(CAG)的患者分为确诊的冠心病组94例与正常对照组36例,其中冠心病组又分为急性心肌梗死(AMI)组25例、不稳定型心绞痛(UAP)组36例和稳定型心绞痛(SAP)组33例;再将冠心病组按CAG结果分为轻度病变组24例、中度病变组27例和重度病变组43例.用免疫透射比浊法分别测定DD、Fg含量进行比较.结果 AMI、UAP两组DD、Fg含量及阳性检出率明显高于SAP和对照组(P＜0.05),AMI组的DD、Fg含量明显高于UAP组(P＜0.05),重度病变组DD、Fg含量高于轻、中度病变组(P＜0.05).结论 联合检测DD与Fg在冠心病的诊断中具有重要的临床意义. Abstract： Objective To examine the diversity of D -dimer(DD) and fibrinogen (Fg)in the patients with coronary heart disease(CHD). Methods The 130 subjects were divided into CHD group(94 cases) which were confirmed by coronary artery angiography(CAG) and control group (36 cases). CHD group was divided into acute myocardial infarction (AMI) group (25 cases), unstable angina pectoris (UAP) group (36 cases) and stable angina pectoris (SAP) group ( 33 cases). In addition, CHD group was divided into slight (24 cases), moderate (27 cases)and severe (43 cases)lesion groups according to the outcome of CAG. The levels of DD and Fg were measured respectively and compared among all groups. Results The levels of DD, Fg in AMI and UAP groups were significantly elevated as compared with that of SAP and control groups ( P＜0.05), and DD, Fg in AMI group were higher than that of UAP group. The levels of DD and Fg in severe lesion group were higher than that of moderate and slight groups ( P＜0.05 ). Conclusions To measure the levels of DD and Fg simultaneously has important clinical significance in CHD.     

CHANGES OF SERUM TYROSINE IN YIN-DEFICIENT PATIENTS WITH CORONARY HEART DISEASE

The mean serum tyrosine concentrationswere 1.14 mg/dl for normal control group(17cases)and 1.43 for patients with coronary heartdisease(CHD)(67 cases),a significantly higherfigure in the latter.No significant differencewas found between male and female patients.Averages of the serum tyrosine levels of Yin-deficient(43 cases)and Yang-deficient(24 cases)groups were 1.50 and 1.29 mg/dl respectively.The differences were statistically significantbetween the two deficiency groups and betweenthe Yin-deficient and normal control groups.The values of male or female Yang-deficientpatients were not however significantly differentfrom the normal.We considered the increaseof serum tyrosine level in CHD patients possiblyto be one of the important pathologic biochemi-cal changes of Yin-deficiency.We found nosuch relationship between the tyrosine level andthe CHD as reported by some foreign investiga-tors.     

探讨血清视黄醇结合蛋白4与冠心病的相关性

目的 观察冠心病患者血清视黄醇结合蛋白4(RBP4)水平,并探讨RBP4与冠心病的关系.方法 64例冠心病患者分为急性心肌梗死(AMI)组10例,不稳定型心绞痛(UAP)组42例,稳定型心绞痛(SAP)组12例,另选择21例冠状动脉造影结果正常者为对照组.采用酶联免疫吸附法(ELISA)测定血清RBP4水平.结果 血清RBP4在AMI和UAP组中高于SAP组和对照组,差异有统计学意义(P＜0.05),在SAP组与对照组之间差异无统计学意义(P＞0.05);血清RBP4在单支、双支、三支病变组中均高于对照组(P＜0.05),但在单支、双支与三支病变组之间差异均无统计学意义(P＞0.05).结论 RBP4可作为预测斑块稳定性的标志物,为冠心病危险分层及采取积极干预措施提供依据,但不能反映冠状动脉狭窄程度及范围. Abstract： Objective To investigate the serum retinol - binding protein 4 ( RBP 4 ) of coronary heart disease (CHD)patients and evaluate whether plasma macrophage migration inhibitory factor were associated with CHD. Methods Sixty -four patients with CHD were divided into the acute myocardial infarction (AMI) group ( n = 10), the unstable angina pectoris (UAP) group ( n = 42) and the stable angina pectoris(SAP) ( n = 12),21 normal subjests without CHD diagnosed by CAG served as the control group. The serum level of RBP4 measured by enzyme linked immune sorbent assay (ELISA). Results The serum level of RBP4 were higher in AMI and UAP group thai in SAP group and control group ( P ＜ 0. 05 ). The mean level of RBP4 in SAP group was not differently significantly, compared with that in control ( P ＞ 0. 05 ) ;The mean level of in single, double and three vessel lesion group were higher than that in control group (P ＜0. 05 ),but the serum levels of RBP4 among single, double and three were not significant different ( P ＞ 0. 05).Conclusions RBP4 may act as one of vulnerable plaques,we can take active to stabilize vulnerable plaques and decrease the occurrence of cardiac events,but may not reflect the severity of artery stenosis.     

Apolipoprotein E polymorphism in the early onset of coronary heart disease

Objective To assess the relationship between apolipoprotein E (apoE) polymorphism and the early onset of coronary heart disease (CHD) and the effect of apoE on lipids and lipoproteins in healthy Chinese subjects. Methods Sixty-eight patients with CHD younger than 55 years (CHD1), 136 patients with CHD older than 65 years (CHD2), and 136 healthy subjects were enrolled, and their plasma levels of triglyceride (TG), total cholesterol (TC) and high density lipoprotein cholesterol (HDL-C) were determined. The apoE genotypes were identified by polymerase chain reaction-restriction fragment length polymorphism.Results apoE 3/4 genotype and E4 allele frequency in the CHD1 group were higher than those in the CHD2 group and healthy subjects, while no differences were found between CHD2 and healthy subjects. Meanwhile, the plasma levels of TC and low density lipoprotein cholesterol (LDL-C) were higher in the CHD2 group than in both CHD1 group and healthy subjects.Each apoE isoprotein has variable TC and LDL-C levels that is E2 (E2/2+E2/3)＜E3(E3/3)&lt;E4(E4/4+E3/4). Conclusion apoE is one of the genetic factors that affect TC and LDL-C levels, and apoE 4 has a very close relation to CHD, suggesting that apoE 4 is an independent genetic factor of the early onset of CHD.     

The changes of Hs-CRP and WBC count after percutaneous coronary intervention in different types of coronary heart diseases

Objective: To investigate the regulation of High sensitive C-reactive protein(Hs-CRP) and WBC count in patients with coronary heart disease(CHD) by percutaneous transluminal intervention(PCI) and to discuss the mechanism of inflammatory reaction after coronary stenting. Methods:127 patients who received successful percutaneous transluminal coronary stenting, were divided into groups of stable angina(SAP), unstable angina(UAP), and acute myocardial infarction(AMI) according to their clinical types. Another 41 stable angina patients with more than 7o% of coronary artery tenosis who did not receive PCI served as control. Serum Hs-CRP levels and WBC count were determined before intervention, 3 days and 7 days post PCI and the data were analyzed statistically by t-test. Results: There showed no difference in clinical baseline characteristics between groups. The serum Hs-CRP level and WBC count was gradually raised in the UAP and AMI group(how about SAP group, and had no difference in CAG group and SAP group). After PCI serum Hs-CRP levels and WBC counts were significantly higher in the SAP group than in the coronary angiography group(CAG) at 3 days and had no difference at 7 days. In the UAP and AMI group, the serum Hs-CRP level at 3 days and 7 days declined obviously, however serum WBC count did not decrease apparently. Conclusion: The serum Hs-CRP level and WBC count elevate transiently after PCI. There are different inflammatory reactions in different types of coronary heart diseases after coronary stenting procedure.     

阿托伐他汀对冠心病合并充血性心力衰竭患者血管内皮功能的影响

目的 研究阿托伐他汀对冠心病(CHD)合并充血性心力衰竭(CHF)患者血浆中一氧化氮(NO)、降钙素基因相关肽(CGRP)和内皮素(ET)的影响.方法 将68例CHD并CHF患者随机分为两组,常规治疗组(地高辛、氢氯噻嗪、硝酸异山梨酯)34例,联用组常规用药加阿托伐他汀34例,另选34例健康体健者为正常对照组.采用Greiss法测定NO水平,放射性免疫法测定治疗前后血中CGRP和ET的水平.结果 CHD并CHF患者中NO和CGRP水平明显低于正常组(P＜0.01),ET显著高于正常组(P＜0.01),治疗后均显著改善(P＜0.01),且以联用组改善更为显著,与常规组治疗后比较差异有统计学意义(P＜0.05).结论 常规用药加阿托伐他汀能显著改善CHD合并CHF患者的NO、CGRP和ET的代谢失衡. Abstract： Objective To study the effect on levels of plasma calcitonin gene-related peptide (CGRP) and endothelin(ET) of atorvastatin in patients with coronary artery heart disease(CHD) complicated with congestive heart failure(CHF). Methods Patients with CHD complicated with CHF were divided into two groups usual medicine group(usual medicine) and atorvastatin group. The plasma CGRP and ET levels were observed before and after treatment. Results The levels of CGRP in patients with CHF were lower than that in normal group before treatment (P＜0.05),and the level of ET was higher (P＜0.05),the improvement of CGRP and ET in atorvastatin group was better than that in the usual medicine group(P＜0.05). Conclusions Atorvastatin had the action of improving the imbalance of CGRP and ET in Patients with CHD complicated with CHF.     

冠心病合并2型糖尿病患者冠状动脉造影临床分析

目的 探讨冠心病合并2型糖尿病患者冠状动脉造影的特点.方法 选择120例冠心病患者进行冠状动脉造影,其中合并糖尿病60例,无糖尿病60例,根据临床特点及造影结果进行对比.结果 冠心病合并糖尿病患者冠状动脉血管病变明显重于单纯冠心病组.多表现为多支血管病变及弥漫性病变(P＜0.05).结论 冠心病合并糖尿病患者冠状动脉造影主要表现为广泛和严重的冠状动脉血管病变. Abstract： Objective To study the coronary artery disease characteristics by coronary angiography in coronary heart diseases patients with type 2 diabetes mellitus. Methods 120 cases of coronary heart disease were treated with coronary angiography, including 60 cases with type 2 diabetes,60 cases of non -diabetic, clinical characteristics and imaging results were compared. Results Coronary artery disease in patients with coronary artery disease with diabetes mellitus was more serious than the other group ( P ＜ 0.05). Conclusions Coronary angiography in patients with coronary heart disease with diabetes mellitus for coronary artery disease mainly manifested more extensive and severe.     

血管回声跟踪技术检测颈动脉弹性变化及主动脉瓣钙化与冠心病的相关性

目的 应用血管回声跟踪技术检测颈动脉弹性变化及二维超声观察主动脉瓣钙化,研究二者与冠状动脉粥样硬化关系及预测价值.方法 应用血管回声跟踪技术对196例行冠脉造影(CAG)受检者进行颈总动脉检查,记录血管弹性指标,包括弹性系数(Ep)、僵硬度(β)、顺应性(AC)、脉搏波传导速度(PWVβ).同时二维超声观察主动脉瓣有无钙化,并将上述结果与CAG结果进行t检验.结果 颈动脉弹性减退与冠脉病变的相关性:β、Ep与CHD呈正相关(r=0.281,r=0.253,P＜0.01,P＜0.05),AVC与CHD呈正相关(r=0.173,P＜0.05).结论 颈动脉弹性减退及主动脉瓣钙化是冠心病的高危因素,对冠心病有较大的预测价值. Abstract： Objective To study the relationship and predictive value of variation of carotid artery elasticity detected by echotracking (ET) technique and aortic valve calcification detected by two - dimensional ultrasonography with coronary heart disease (CHD). Methods The carotid artery elasticity of 196 cases who underwent coronary angiography(CAG) for suspected CHD were detected by echotracking (ET) technique and the indicators of artery elasticity were recorded, which includes elasticity modulus ( Ep), stiffness parameter ( β ), arterial compliance ( AC ) and pulse wave velocity ( PWVβ ).And aortic valve calcification was detected by two - dimensional ultrasonography, T test was carried out between the results of ultrasound examination and CAG. Results The indicators β, EP of carotid artery elasticity were positively correlated with the extent of CHD( r =0. 281,0.253; P ＜ 0.01, ＜ 0.05). In the mean time, positive correlation between aortic valve calcification and the extent of CHD was found (r = 0. 173, P ＜ 0.05). Conclusions Carotid artery elasticity reducing and AVC are high risk factors of CHD and have great values in predicting CHD.     

超敏C-反应蛋白与白细胞介素-6在2型糖尿病合并冠心病患者中的表达和关系

目的 探讨超敏C-反应蛋白(hs-CRP)、白细胞介素(IL)-6在2型糖尿病合并冠心病患者中的水平及其关系.方法 将2型糖尿病患者80例分为合并冠心病组(40例)和单纯糖尿病组(40例),另选40例为正常对照组.比较各组间血清hs-CRP、IL-6、血脂的水平.结果 2型糖尿病组hs-CRP、IL-6水平明显高于对照组(P<0.01);2型糖尿病合并冠心病组hs-CRP、IL-6水平明显高于单纯糖尿病组(P<0.01).结论 血清中的hs-CRP及IL-6 水平与2型糖尿病合并冠心病密切相关,二者可能发挥协同作用. Abstract： Objective To investigate the correlationship between high sensitive C-reactive protein(hs-CRP)and interleukin-6(IL-6)in patients with diabetes mellitus complicated with coronary artery disease. Methods Eighty patients with T2DM were divided into two groups:40 cases complicated with coronary artery disease,40 cases without coronary artery disease, and 40 healthy people as control group. The levels of serum hs-CRP, blood lipid and IL-6 were compared between patients of three groups.Results Levels of hs-CRP and IL-6 were significantly higher in patients with T2DM than those in control group(P<0.01);and were significantly higher in patients with coronary artery disease than those without coronary artery disease(P<0.01).Conclusions Levels of hs-CRP and IL-6 were significantly higher in patients with T2DM complicated with coronary artery disease, and the close correlationship between hs-CRP and IL-6 may contribute to the pathogenesis of this process.     

血清胆红素和血脂对冠心病发生的作用

目的 探讨血清胆红素和血脂在冠心病发生中的作用.方法 75例冠心病患者被分为高脂血症组(46例)和非高脂血症组(29例),35例正常健康成人作为对照组,分别测定血清总胆红素(TBIL)、直接胆红素(DBIL)、间接胆红素(IBIL)以及总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)和高密度脂蛋白(HDL)水平等指标作对比分析.结果 高脂血症组TBIL、DBIL、IBIL均低于非高脂血症组和正常对照组,差异有统计学意义(P＜0.05);非高脂血症组血清胆红素水平低于正常对照组,差异有统计学意义(P＜0.05).高脂血症组同非高脂血症组、正常对照组比较,TC、TG和LDL增高,HDL降低,差异有统计学意义(P＜0.05);非高脂血症组同正常对照组比较,TC、TG和LDL增高,HDL降低,但差异无统计学意义(P＞0.05).结论 低胆红素水平在高脂血症和非高脂血症的冠心病发生中起着重要的作用,是冠心病的独立危险因素. Abstract： Objective To investigate the effection of serum bilirubin and serum lipid on coronary heart disease (CHD). Methods Seventy -five patients with CHD group were divided into hyperlipidemia group(46 cases) and non- hyperlipidemia group (29 cases),35 healthy controls (healthy control group)were enrolled in the study. Serum total bilirubin (TBIL), direct bilirubin (DBIL), indirect bilirubin (IBIL)serum triglycride ( TG), total cholestrol ( TC ), low density lipoprotein (LDL), high density lipoprotein (HDLand serum lipid were examined for all subiects,and then the results were compared and analyzed. Results The contents of serum TBIL, direct bilirubin (DBIL), indirect bilirubin (IBIL)were lower in hyperlipidemia group than those of non - hyperlipidemia and healthy control group, the difference was significant (P ＜0. 05 ). The contents of serum bilirubin were lower in non - hyperlipidemia group than those of healthy control group, the difference was significant( P ＜ 0.05 ). TC,TG and LDL were higher and HDL was lower in hyperlipidemia group than those of healthy control group and non - hyperlipidemia group, the difference was significant( P ＜0.05). TC,TG and LDL were higher and HDL was lower in non -hyperlipidemia group than those of healthy control group,There was no difference in the two groups( P ＞0.05). Conclusions The lower serum bilirubin level is an independent risk factor of coronary heart disease in hyperlipidemia and non- hyperlipidemia groups.     

冠心病与血清高敏C反应蛋白、尿酸及血脂水平的检测与结果分析

目的 探讨冠心病患者血清高敏C反应蛋白(hs-CRP)、尿酸(UA)及血脂水平变化及临床意义.方法 抽取冠心病与健康对照组清晨空腹静脉血,应用全自动生化分析仪对血清hs-CRP、UA、血脂进行检测.结果 冠心病组高密度脂蛋白胆固醇(HDL-C)、载脂蛋白AI(apoAI)含量低于健康对照组;hs-CRP、UA、甘油三酯(TG)、胆固醇、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白B(apoB)浓度高于健康对照组.结论 血清hs-CRP、UA及血脂水平的联合检测对冠心病的诊断具有重要意义. Abstract： Objective Discussion coronary disease blood serum high sensitivity C-reactive protein (hs-CRP),the blood lipids and the uric level change and clinical significance. Methods Extraction coronary disease group with the healthy control group early morning the empty stomach venous blood, applied the whole blood to move the biochemistry analyzer to the blood serum hs-CRP, the uric acid, the blood lipids carries on the examination. Results The coronary disease group blood serum the high density lipoprotein cholesterol and carry the lipoprotein AI content were lower than that in the healthy control group. The hs-CRP, the uric acid, the triglyceride, the low density lipoprotein cholesterol, carry lipoprotein B were higher than that in the control group. Conclusions Combined determination of the patient blood serum hs-CRP, uric acid, blood lipids level is important for the diagnosis of coronary artery disease.